MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Cash and Bank History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash and Bank | ₹453 Cr | ₹406 Cr | ₹701 Cr | ₹420 Cr | ₹141 Cr |
What is the latest Cash and Bank ratio of MANKIND PHARMA ?
Year | Cash and Bank |
---|---|
Mar2023 | ₹453 Cr |
Mar2022 | ₹406 Cr |
Mar2021 | ₹701 Cr |
Mar2020 | ₹420 Cr |
Mar2019 | ₹141 Cr |
How is Cash and Bank of MANKIND PHARMA Trending?
Years | Cash and Bank | % Change | |
---|---|---|---|
Mar2023 | ₹453 Cr | 11.64 | |
Mar2022 | ₹406 Cr | -42.07 | |
Mar2021 | ₹701 Cr | 66.89 | |
Mar2020 | ₹420 Cr | 197.76 | |
Mar2019 | ₹141 Cr | - |
Compare Cash and Bank of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹83,865.6 Cr | -4% | -8.3% | 51.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,470.0 Cr | 0.4% | -0.4% | 61.2% | Stock Analytics | |
CIPLA | ₹112,990.0 Cr | -1.1% | 1.7% | 53.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,846.0 Cr | 5.9% | 11.3% | 94.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,849.0 Cr | -0.1% | 3.9% | 20% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,742.1 Cr | -2% | -4.2% | 29.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -4% |
-8.3% |
51.1% |
SENSEX | 1.7% |
0.7% |
19.2% |
You may also like the below Video Courses